We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAM
2101
Adamas Trust
ADAM
$815M
| $690K | ﹤0.01% |
27,968
-4,958
| -15% | -$125K |
|
2102
Axogen
AXGN
$2.27B
| $685K | ﹤0.01% |
24,203
-4,907
| -17% | -$116K |
|
2103
Cass Information Systems
CASS
$714M
| $685K | ﹤0.01% |
14,130
-2,534
| -15% | -$127K |
|
2104
Atkore
ATKR
$2.46B
| $683K | ﹤0.01% |
31,863
-5,863
| -16% | -$118K |
|
|
AXDX
2105
DELISTED
Accelerate Diagnostics
AXDX
| $683K | ﹤0.01% |
2,609
-505
| -16% | -$118K |
|
|
KBAL
2106
DELISTED
Kimball International
KBAL
| $683K | ﹤0.01% |
36,572
-6,381
| -15% | -$120K |
|
|
SSNI
2107
DELISTED
Silver Spring Networks, Inc.
SSNI
| $681K | ﹤0.01% |
41,920
-6,979
| -14% | -$113K |
|
2108
Kforce
KFRC
$1.02B
| $674K | ﹤0.01% |
26,693
-3,636
| -12% | -$85.5K |
|
|
DSPG
2109
DELISTED
DSP Group Inc
DSPG
| $672K | ﹤0.01% |
53,794
+7,163
| +15% | +$94.3K |
|
2110
Precigen
PGEN
$2.24B
| $671K | ﹤0.01% |
58,277
+221
| +0.4% | +$3.29K |
|
2111
Great Southern Bancorp
GSBC
$874M
| $670K | ﹤0.01% |
12,963
+840
| +7% | +$45.2K |
|
|
CWEN.A
2112
DELISTED
Clearway Energy Class A
CWEN.A
| $668K | ﹤0.01% |
35,452
-6,304
| -15% | -$118K |
|
|
INST
2113
DELISTED
Instructure, Inc.
INST
| $667K | ﹤0.01% |
20,149
-3,748
| -16% | -$128K |
|
|
CTWS
2114
DELISTED
Connecticut Water Service Inc
CTWS
| $666K | ﹤0.01% |
11,608
-1,985
| -15% | -$121K |
|
|
BRSS
2115
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $666K | ﹤0.01% |
20,121
-3,897
| -16% | -$133K |
|
|
GBNK
2116
DELISTED
Guaranty Bancorp
GBNK
| $666K | ﹤0.01% |
24,081
-4,196
| -15% | -$119K |
|
2117
Acushnet Holdings
GOLF
$5.93B
| $665K | ﹤0.01% |
31,562
+418
| +1% | +$7.95K |
|
|
KTWO
2118
DELISTED
K2M Group Holdings, Inc
KTWO
| $664K | ﹤0.01% |
36,906
-7,248
| -16% | -$138K |
|
|
PRO
2119
DELISTED
PROS Holdings
PRO
| $663K | ﹤0.01% |
25,060
-4,683
| -16% | -$117K |
|
|
ARII
2120
DELISTED
American Railcar Industries, Inc.
ARII
| $662K | ﹤0.01% |
15,895
-1,500
| -9% | -$59.1K |
|
|
REVG
2121
DELISTED
REV Group
REVG
| $660K | ﹤0.01% |
20,286
+5,505
| +37% | +$151K |
|
|
AHT
2122
Ashford Hospitality Trust
AHT
$20.9M
| $659K | ﹤0.01% |
99
-23
| -19% | -$152K |
|
2123
Evolent Health
EVH
$348M
| $659K | ﹤0.01% |
53,553
-921
| -2% | -$13K |
|
2124
Vanda Pharmaceuticals
VNDA
$307M
| $657K | ﹤0.01% |
43,196
-8,125
| -16% | -$121K |
|
2125
PTC Therapeutics
PTCT
$5.64B
| $654K | ﹤0.01% |
39,196
-2,907
| -7% | -$49.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.